To further predict the potential RNF114 regulatory pathway in HER2-positive BC cells, transcriptome sequencing was conducted to identify differentially expressed genes (DEGs) following RNF114 knockdown in SKBR3 cells (Figure 3A). The gene discussed is ERBB2; the disease is breast cancer.